Atlas Trials

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Clinical trial NCT01118962 · COMPLETED

Trial details

NCT number
NCT01118962
Sponsor
UCB BIOSCIENCES, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Epilepsy
Start date
2010-08-01
Primary completion
2012-10-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.